Related Experiment Video
Updated: Jun 8, 2026

Method of Direct Segmental Intra-hepatic Delivery Using a Rat Liver Hilar Clamp Model
Published on: April 2, 2017
Lecithinized superoxide dismutase treatment improves steroid-refractory interstitial pneumonia
Tatsuo Kawashima1, Toru Wakabayashi, Toshihisa Kuroda
1Department of Internal Medicine, Toho University Sakura Medical Center, Shimoshizu, Sakura, Japan. t-kawashima@sakura.med.toho-u.ac.jp
Abstract:
Pulmonary fibrosis associated with amyopathic dermatomyositis is known to have a generally aggressive course and is ultimately fatal. We report the case of a 50-year-old patient with amyopathic dermatomyositis, who developed progressive interstitial pneumonia that was unresponsive to corticosteroids and multiple immunosuppressive agents, including cyclosporine and tacrolimus hydrate. Five courses of lecithinized superoxide dismutase were administered without adverse effects. Improvements in physiological parameters, such as pulmonary function and exercise tolerance, as well as the serum Krebs von den Lungen 6 level, were observed. This is the first report of a case of steroid-refractory interstitial pneumonia treated with lecithinized superoxide dismutase.
Related Concept Videos
COPD: Management Using Bronchodilators and Corticosteroids
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation